4.5 Article

Real-life experience of using pegylated liposomal doxorubicin in primary cutaneous T-cell lymphomas

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Elise A. Olsen et al.

Summary: The number of patients with primary cutaneous lymphoma (PCL) is small compared to other non-Hodgkin lymphomas (NHLs), and there are many subtypes. Clinical trial guidelines for PCL, except for mycosis fungoides/Sezary syndrome, are lacking. To address this gap, international dermatology organizations propose updated staging and guidelines aligned with the Lugano guidelines, aiming to facilitate regulatory approval, encourage cooperative trials, and assess comparative efficacy of therapeutic agents.
Article Hematology

Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas

Stefano Pulini et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)